Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Compound Danshen Dripping Pill in Patients With Diabetic Microvascular Angina

NCT06727890 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06727890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06727890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Compound Danshen Dripping Pill in Patients With Diabetic Microvascular Angina
Lead sponsor
Qilu Hospital of Shandong University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2025
Completion date
June 30, 2027
Enrollment
162 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic microvascular angina